Clinical Trials Start for Taiwan-Made Drug to Treat COVID-19

Published

By Rick Yi/Philip Brossard

A Taiwan pharma company has started phase-3 trials for a drug to treat COVID-19. The recent spike in cases has given the company the sample size it needs to find out if the medicine works.